Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Goate

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Neurology. Genetics|November 30, 2017
The Alzheimer's Disease Sequencing Project: Study design and sample selectionGary W Beecham, J C Bis, E R Martin, et al.
American Journal of Medical Genetics|February 25, 2000
Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigreesT Foroud, P F Castelluccio, D L Koller, et al.
Molecular Psychiatry|January 11, 2017
An endophenotype approach to the genetics of alcohol dependence: a genome wide association study of fast beta EEG in families of African ancestryJ L Meyers, J Zhang, J C Wang, et al.
Nature|September 13, 1990
Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorderP H St George-Hyslop, J L Haines, L A Farrer, et al.
Molecular Psychiatry|August 5, 2015
Evidence of CNIH3 involvement in opioid dependenceE C Nelson, A Agrawal, A C Heath, et al.
Nature|June 26, 1998
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17M Hutton, C L Lendon, P Rizzu, et al.
Molecular Psychiatry|August 5, 2015
Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African AmericansE Olfson, N L Saccone, E O Johnson, et al.
The Lancet. Neurology|March 22, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trialRandall J Bateman, Yan Li, Eric M McDade, et al.
Nature Medicine|June 22, 2021
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseStephen Salloway, Martin Farlow, Eric McDade, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU TrialRandall J Bateman, Yan Li, Eric M McDade, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Neurology. Genetics|November 30, 2017
The Alzheimer's Disease Sequencing Project: Study design and sample selectionGary W Beecham, J C Bis, E R Martin, et al.
American Journal of Medical Genetics|February 25, 2000
Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigreesT Foroud, P F Castelluccio, D L Koller, et al.
Molecular Psychiatry|January 11, 2017
An endophenotype approach to the genetics of alcohol dependence: a genome wide association study of fast beta EEG in families of African ancestryJ L Meyers, J Zhang, J C Wang, et al.
Nature|September 13, 1990
Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorderP H St George-Hyslop, J L Haines, L A Farrer, et al.
Molecular Psychiatry|August 5, 2015
Evidence of CNIH3 involvement in opioid dependenceE C Nelson, A Agrawal, A C Heath, et al.
Nature|June 26, 1998
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17M Hutton, C L Lendon, P Rizzu, et al.
Molecular Psychiatry|August 5, 2015
Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African AmericansE Olfson, N L Saccone, E O Johnson, et al.
The Lancet. Neurology|March 22, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trialRandall J Bateman, Yan Li, Eric M McDade, et al.
Nature Medicine|June 22, 2021
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseStephen Salloway, Martin Farlow, Eric McDade, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU TrialRandall J Bateman, Yan Li, Eric M McDade, et al.
Pageof 8